Verrica Pharmaceuticals Inc.
VRCA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660334
In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Verrica Pharmaceuticals Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +4 vs. Q1 2026
- Shares held
- 4.66M
- −115.2K (−2.4%) vs. Q1 2026
- Total value
- $28.5M
- +$3.26M (+12.9%) vs. Q1 2026
- New holders
- 9
- 7 more added
- Sold out
- 5
- 11 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRCA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 43 | $28.5M |
| Q1 2026 | 39 | $25.3M |
| Q4 2025 | 50 | $43.2M |
| Q3 2025 | 34 | $10.6M |
| Q2 2025 | 59 | $13.4M |
| Q1 2025 | 75 | $13.0M |
| Q4 2024 | 81 | $21.0M |
| Q3 2024 | 79 | $21.6M |
| Q2 2024 | 74 | $136.0M |
| Q1 2024 | 62 | $106.7M |
| Q4 2023 | 64 | $132.7M |
| Q3 2023 | 67 | $58.5M |
| Q2 2023 | 63 | $84.2M |
| Q1 2023 | 60 | $93.0M |
| Q4 2022 | 50 | $29.8M |
| Q3 2022 | 49 | $29.9M |
| Q2 2022 | 57 | $21.8M |
| Q1 2022 | 51 | $72.1M |
| Q4 2021 | 45 | $115.2M |
| Q3 2021 | 49 | $114.6M |
| Q2 2021 | 53 | $153.1M |
| Q1 2021 | 51 | $150.4M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Verrica Pharmaceuticals Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Caligan Partners LP | 923,910 | $5.65M | 0.27% | 00.0% | Unchanged |
| Cannell Capital LLC | 783,923 | $4.80M | 3.35% | +98,800+14.4% | Added |
| Affinity Asset Advisors, LLC | 707,338 | $4.33M | 0.21% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 471,559 | $2.89M | 1.77% | 00.0% | Unchanged |
| Armistice Capital, LLC | 426,304 | $2.61M | 0.07% | −91,877−17.7% | Reduced |
| Boothbay Fund Management, LLC | 280,734 | $1.72M | 0.03% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 279,310 | $1.71M | 0.00% | +90,552+48.0% | Added |
| Mariner, LLC | 207,230 | $1.27M | 0.00% | +182,686+744.3% | Added |
| Geode Capital Management, LLC | 138,160 | $845.7K | 0.00% | −757−0.5% | Reduced |
| BlackRock, Inc. | 74,344 | $455.0K | 0.00% | +35,791+92.8% | Added |
| Vanguard Fiduciary Trust Co | 70,173 | $429.5K | 0.00% | +5,072+7.8% | Added |
| Two Sigma Investments, LP | 40,825 | $249.8K | 0.00% | −9,837−19.4% | Reduced |
| State Street Corp | 28,916 | $177.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 26,996 | $165.2K | 0.00% | −4,584−14.5% | Reduced |
| DAFNA Capital Management LLC | 23,750 | $145.3K | 0.03% | −129,962−84.5% | Reduced |
| Jane Street Group, LLC | 23,654 | $144.8K | 0.00% | −25,557−51.9% | Reduced |
| Verdad Advisers, LP | 23,069 | $141.2K | 0.14% | +10,971+90.7% | Added |
| Renaissance Technologies LLC | 21,769 | $133.2K | 0.00% | −10,591−32.7% | Reduced |
| Legacy Trust | 16,584 | $101.5K | 0.02% | −650−3.8% | Reduced |
| Fifth Third Bancorp | 14,000 | $85.7K | 0.00% | +14,000 | New |
| Dimensional Fund Advisors LP | 13,888 | $85.0K | 0.00% | +13,888 | New |
| XTX Topco Ltd | 13,723 | $84.0K | 0.00% | +13,723 | New |
| Two Sigma Securities, LLC | 13,045 | $79.8K | 0.01% | +13,045 | New |
| HRT Financial LP | 13,023 | $79.0K | 0.00% | +13,023 | New |
| Beck Mack & Oliver LLC | 12,000 | $73.4K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 6,071 | $37.2K | 0.00% | +1,801+42.2% | Added |
| Morgan Stanley | 3,201 | $19.6K | 0.00% | −19,185−85.7% | Reduced |
| Capital Analysts, LLC | 1,500 | $9.00K | 0.00% | 00.0% | Unchanged |
| Vanguard Global Advisers, LLC | 862 | $5.28K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 764 | $5.00K | 0.00% | −201−20.8% | Reduced |
| Tower Research Capital LLC (TRC) | 614 | $3.76K | 0.00% | −242−28.3% | Reduced |
| Salomon & Ludwin, LLC | 290 | $1.72K | 0.00% | 00.0% | Unchanged |
| Allied Private Wealth LLC | 202 | $1.34K | 0.00% | +202 | New |
| New England Capital Financial Advisors LLC | 200 | $1.22K | 0.00% | 00.0% | Unchanged |
| International Assets Investment Management, LLC | 175 | $1.04K | 0.00% | 00.0% | Unchanged |
| Fortitude Family Office, LLC | 127 | $777 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 110 | $673 | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 102 | $624 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 64 | $392 | 0.00% | +64 | New |
| JPMorgan Chase & Co | 47 | $306 | 0.00% | 00.0% | Unchanged |
| Ameritas Advisory Services, LLC | 30 | $184 | 0.00% | +30 | New |
| Jones Financial Companies LLLP | 26 | $178 | 0.00% | 00.0% | Unchanged |
| Valley National Advisers Inc | 25 | $153 | 0.00% | +25 | New |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −140,497−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −99,735−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −75,208−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −2−100.0% | Sold out |